Kimia Farma Persero Stock Cash Per Share
| KAEF Stock | IDR 610.00 10.00 1.67% |
Kimia Farma Persero fundamentals help investors to digest information that contributes to Kimia Farma's financial success or failures. It also enables traders to predict the movement of Kimia Stock. The fundamental analysis module provides a way to measure Kimia Farma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kimia Farma stock.
Kimia |
Kimia Farma Persero Company Cash Per Share Analysis
Kimia Farma's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Kimia Farma Cash Per Share | 122.65 X |
Most of Kimia Farma's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kimia Farma Persero is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Kimia Farma Persero has a Cash Per Share of 122 times. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The cash per share for all Indonesia stocks is notably lower than that of the firm.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Kimia Fundamentals
| Return On Equity | -0.026 | |||
| Return On Asset | 0.0089 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 14.62 T | |||
| Shares Outstanding | 5.55 B | |||
| Shares Owned By Insiders | 95.80 % | |||
| Shares Owned By Institutions | 0.07 % | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 0.60 X | |||
| Revenue | 12.86 T | |||
| Gross Profit | 4.05 T | |||
| EBITDA | 1.23 T | |||
| Net Income | 302.27 B | |||
| Cash And Equivalents | (1.54 B) | |||
| Cash Per Share | 122.65 X | |||
| Total Debt | 3.25 T | |||
| Debt To Equity | 1.09 % | |||
| Current Ratio | 1.01 X | |||
| Book Value Per Share | 1,298 X | |||
| Cash Flow From Operations | (223.92 B) | |||
| Earnings Per Share | 7.09 X | |||
| Target Price | 2170.0 | |||
| Number Of Employees | 11.51 K | |||
| Beta | -0.11 | |||
| Market Capitalization | 5.78 T | |||
| Total Asset | 17.76 T | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 0.69 % | |||
| Net Asset | 17.76 T |
About Kimia Farma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kimia Farma Persero's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kimia Farma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kimia Farma Persero based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Kimia Stock
Kimia Farma financial ratios help investors to determine whether Kimia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kimia with respect to the benefits of owning Kimia Farma security.